Norway
Picterus AS, a Norwegian
health care startup, has developed a smartphone app to estimate jaundice levels in newborns, with the aim of preventing deaths and brain damage. The company was established in
2015 and has received a grant investment from
The European Innovation Council as of
23 June 2023. Currently, approximately 114,000 infants lose their lives annually due to jaundice, making it a major cause of mortality and brain impairment, especially in underdeveloped and developing countries. Picterus AS's innovative solution addresses a critical need in the healthcare industry by providing a cost-effective and accessible tool for early detection and intervention. The company's focus on leveraging technology for social impact presents a promising opportunity for investors seeking both financial returns and positive societal outcomes. With its headquarters in
Norway, Picterus AS is well-positioned to expand its reach and make a meaningful difference on a global scale.
